Topamax lawyers at Pintas & Mullins are reviewing cases involving women who took the drug Topamax® during their first trimester of pregnancy and had a baby born with an oral cleft deformity (oral cleft lip and/or palate) or serious fetal or skeletal deformities. Topamax and its generic versions under the name topiramate are approved for use in the United States to treat both epilepsy and severe migraine headaches.

Topamax (topiramate) is a prescription drug approved for use in the United States to treat both epilepsy and severe migraine headaches. An off-label use for Topamax is as a weight loss treatment.

On March 4, 2011, the FDA announced that, based on new data from the NAAED Pregnancy Registry, Topamax will be reclassified from a Pregnancy Category C to a Category D. The new data suggests that babies exposed to Topamax during the first trimester of pregnancy have a significant increased risk of cleft lip and cleft palate, as well as genital deformities and other fetal or skeletal malformations. These findings follow a 2008 study by the medical journal Neurology that reported similar findings linking Topamax to an unusually high rate of serious birth defects like oral clefts.

Contact our Experienced Attorneys

The lawyers at the Pintas & Mullins Law Firm have extensive knowledge about drug litigation. If you or a loved one has delivered a child with an oral cleft deformity as a result of taking Topamax, contact our office immediately. Each drug case is unique, and most have a specific time frame in which you can file. Our law firm can provide you with a free no-obligation consultation and explain your legal rights.